Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
The Biotechnology Innovation Organization (BIO) and patient advocacy organizations have seen some recent progress in their efforts to have Congress pass pharmacy benefit manager […]
House and Senate advance PBM legislation, advocacy groups urge passage Read More »
COVID was “a tragedy around the world,” said Rachel King, President and CEO of the Biotechnology Innovation Organization (BIO). However, COVID-19 also brought “amazing
For global health security, we need public-private partnership Read More »
Pharmacy benefit managers, or PBMs, have been in the political hot seat for a couple of years now—and for good reason. “Every day PBMs
As PBM reform maintains steam, biotech companies and patients are urged to take action Read More »
As weakening investment plagues small, innovative biotechs on both sides of the Atlantic, one bright spot in providing funding is acquisitions—though even that vital
M&A activity a bright spot in funding for biotech, expert tells 2023 BIO-Europe Read More »
Remarks from Dr. Ted W. Love, Chairman of the Biotechnology Innovation Organization (BIO) and former President and CEO of Global Blood Therapeutics, as prepared
Dr. Ted W. Love: How to reframe the narrative about biotech – and put patients first Read More »
The law on every company’s and investor’s mind: the Inflation Reduction Act (IRA), which allows the government to set the prices of certain drugs.
How is the Inflation Reduction Act affecting biotech investment? Read More »
Indiana Governor Eric Holcomb was named Governor of the Year for 2023, an award presented by the Biotechnology Innovation Organization (BIO) to recognize governors’
Indiana’s Eric Holcomb named Governor of the Year Read More »
Over the past week, the biotech and pharmaceutical community has responded to the October 7 terrorist attack on Israel. “The tragic loss of life
BIO and biotech sector speak out on terrorist attack in Israel Read More »
Biotech was front and center as Biotechnology Innovation Organization (BIO) CEO Rachel King met with Maryland Governor Wes Moore at the University of Maryland
BIO CEO meets Maryland Governor to highlight state’s vital relationship with biotech Read More »
The Biotechnology Innovation Organization (BIO) is surveying biotech companies about their interactions with the Food and Drug Administration (FDA), with the goal of improving
BIO surveying biotech firms on how to improve communications with the FDA Read More »
